<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) is characterized by numerous <z:hpo ids='HP_0001507'>growth abnormalities</z:hpo> and an increased risk of <z:e sem="disease" ids="C1368871" disease_type="Neoplastic Process" abbrv="">childhood tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The gene for BWS is localized in the 11p15.5 region, as determined by linkage analysis of <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> pedigrees </plain></SENT>
<SENT sid="2" pm="."><plain>The increased maternal transmission pattern seen in the <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo>-type pedigrees and the findings of paternal <z:mp ids='MP_0008867'>uniparental disomy</z:mp> reported for a subgroup of patients indicate that the gene for BWS is imprinted </plain></SENT>
<SENT sid="3" pm="."><plain>Previously, we found p57KIP2, which is a Cdk-kinase inhibitor located at 11p15, is mutated in two BWS patients </plain></SENT>
<SENT sid="4" pm="."><plain>Here, we screened for the mutation of the gene in 15 BWS patients </plain></SENT>
</text></document>